sunitinib
Showing 1 - 25 of 196
Gastrointestinal Stromal Tumors Trial in Miami (Sunitinib, Regorafenib)
Recruiting
- Gastrointestinal Stromal Tumors
- Sunitinib
- Regorafenib
-
Miami, FloridaUniversity of Miami
Jan 3, 2023
go Back Into Records and Observe How People With Metastatic
Not yet recruiting
- Carcinoma, Renal Cell
- Clear-cell Metastatic Renal Cell Carcinoma
- Sunitinib
-
Istanbul, TurkeyPfizer
Feb 15, 2023
Metastatic and/or Advanced Renal Cell Carcinoma, Treated With
Brain Metastases Trial in Toronto (Sunitinib)
Completed
- Brain Metastases
- Sunitinib
-
Toronto, Ontario, CanadaUniversity Health Network, Princess Margaret Hospital
Oct 6, 2022
Renal Cell Carcinoma Trial in Houston (Sunitinib, Nephrectomy)
Active, not recruiting
- Renal Cell Carcinoma
- Sunitinib
- Nephrectomy
-
Houston, Texas
- +1 more
Oct 11, 2022
Advanced Gastrointestinal Stromal Tumors, Metastatic Cancer Trial in United States (CGT9486 plus sunitinib, CGT9486, Sunitinib)
Recruiting
- Advanced Gastrointestinal Stromal Tumors
- Metastatic Cancer
- CGT9486 plus sunitinib
- +2 more
-
Duarte, California
- +11 more
Aug 10, 2022
Thymoma, Thymus Tumors Trial run by the NCI (Sunitinib)
Active, not recruiting
- Thymoma
- Thymus Neoplasms
- Sunitinib
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
May 17, 2022
Metastatic Renal Cell Carcinoma Trial in Lebanon, Burlington (Sunitinib, Temsirolimus)
Active, not recruiting
- Metastatic Renal Cell Carcinoma
- Sunitinib
- Temsirolimus
-
Lebanon, New Hampshire
- +1 more
Aug 9, 2022
Refractory Solid Tumors Trial in Seoul (Sunitinib)
Completed
- Refractory Solid Tumors
- Sunitinib
-
Seoul, Seoul, Korea, Republic Of, Korea, Republic ofSamsung Medical Center
Jun 13, 2022
Renal Cell Carcinoma, Ovarian Carcinoma, Thyroid Carcinoma Trial in Groningen (Olaparib, Lenvatinib, Sunitinib)
Not yet recruiting
- Renal Cell Carcinoma
- +4 more
- Olaparib
- +4 more
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jul 13, 2023
Renal Cell Carcinoma Trial (Pembrolizumab, Axitinib, Sunitinib)
Active, not recruiting
- Renal Cell Carcinoma
- Pembrolizumab
- +2 more
- (no location specified)
Aug 17, 2022
Real-world Clinical Patterns Of Care And Outcomes Among AfME
Recruiting
- Metastatic Renal Cell Carcinoma
- Sunitinib
-
Algers, Algeria
- +5 more
Aug 16, 2022
Refractory Solid Tumors Trial in Seoul (sunitinib)
Completed
- Refractory Solid Tumors
- sunitinib
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 13, 2022
Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)
Recruiting
- Neoplasms
- +12 more
- Toripalimab
- +3 more
-
Nanjing, Jiangsu, ChinaJinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023
Gliosarcoma, CNS Sarcoma Trial run by the NCI (Sunitinib, wGT3x-BT)
Terminated
- Gliosarcoma
- Central Nervous System Sarcoma
- Sunitinib
- wGT3x-BT
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Mar 24, 2022
Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)
Active, not recruiting
- Prostate Cancer
- Abiraterone Acetate
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 6, 2022
Clear-cell Renal Cell Carcinoma, RCC, Kidney Cancer Trial in Birmingham (Avelumab, Sunitinib)
Withdrawn
- Clear-cell Renal Cell Carcinoma
- +3 more
- Avelumab
- Sunitinib
-
Birmingham, AlabamaUniversity of Alabama Hematology Oncology Clinic at Medical West
Feb 14, 2022
Renal Cell Carcinoma, Metastatic Trial in Worldwide (Intuvax (INN: ilixadencel), Sunitinib)
Completed
- Renal Cell Carcinoma, Metastatic
- Intuvax (INN: ilixadencel)
- Sunitinib
-
Chicago, Illinois
- +27 more
Jul 23, 2022
Paraganglioma, Pheochromocytoma Trial in Canada, Netherlands (Sunitinib)
Active, not recruiting
- Paraganglioma
- Pheochromocytoma
- Sunitinib
-
Calgary, Alberta, Canada
- +3 more
Nov 29, 2021
Renal Cell Carcinoma Metastatic Trial in Hershey (Abemaciclib, Sunitinib)
Active, not recruiting
- Renal Cell Carcinoma Metastatic
- Abemaciclib
- Sunitinib
-
Hershey, PennsylvaniaPenn State Cancer Institute
Jan 5, 2022
Kidney Tumors, Metastatic Renal Cell Cancer Trial in Besancon (Sunitinib)
Active, not recruiting
- Kidney Neoplasms
- Metastatic Renal Cell Cancer
- Sunitinib
-
Besancon, Franche-Comté, FranceCHU Besancon
Nov 17, 2021
CR With Sunitinib Treatment In mRCC Patients
Completed
- Complete Remission in Renal Cell Carcinoma
- sunitinib
-
Marseille, Cedex 5, France
- +13 more
Feb 14, 2022
Renal Cell Carcinoma Trial (Sunitinib)
Not yet recruiting
- Renal Cell Carcinoma
- Sunitinib
- (no location specified)
Sep 11, 2023
Non GIST Sarcomas Trial in France (sunitinib)
Completed
- Non GIST Sarcomas
- sunitinib
-
Bordeaux, France
- +5 more
Jan 3, 2022